Based on our current findings, regardless of ambiguous roles of GPC3 on liver cancer stem cells, GPC3 could be a promising target gene for HCC immunotherapy owing to its specificity on the liver cancer stem cells, and its absence in normal liver stem cells. Here, GPC3 is linked to hepatocellular carcinoma.